MoneyWorks4Me

Concord Biotech - Quaterly Results

23 May 2024 Evaluate
The revenue zoomed 17.02% to Rs. 3189.69 millions for the quarter ended March 2024 as compared to Rs. 2725.85 millions during the corresponding quarter last year.A meek growth of 3.97% was reported for the quarter ended March 2024 to Rs. 972.15  millions from Rs. 935.07 millions.Operating profit surged to 1451.00 millions from the corresponding previous quarter of 1412.61 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 3189.69 2725.85 17.02 10169.39 8531.68 19.20 10169.39 8531.68 19.20
Other Income 108.12 122.00 -11.38 337.80 353.09 -4.33 337.80 353.09 -4.33
PBIDT 1451.00 1412.61 2.72 4653.37 3785.96 22.91 4653.37 3785.96 22.91
Interest 4.63 14.54 -68.16 25.52 45.10 -43.41 25.52 45.10 -43.41
PBDT 1446.37 1398.07 3.45 4627.85 3740.86 23.71 4627.85 3740.86 23.71
Depreciation 137.18 141.84 -3.29 535.92 540.32 -0.81 535.92 540.32 -0.81
PBT 1309.19 1256.23 4.22 4091.93 3200.54 27.85 4091.93 3200.54 27.85
TAX 337.04 321.16 4.94 1044.62 819.28 27.50 1044.62 819.28 27.50
Deferred Tax 37.26 9.45 294.29 46.28 23.82 94.29 46.28 23.82 94.29
PAT 972.15 935.07 3.97 3047.31 2381.26 27.97 3047.31 2381.26 27.97
Equity 104.62 104.62 0.00 104.62 104.62 0.00 104.62 104.62 0.00
PBIDTM(%) 45.49 51.82 -12.22 45.76 44.38 3.12 45.76 44.38 3.12
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..